Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05913> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05913 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05913 label "OSI-930 [drugbank:DB05913]" assertion.
- drugbank:DB05913 seeAlso DB05913 assertion.
- drugbank:DB05913 description "OSI-930 is an orally active inhibitor of two clinically validated targets: c-Kit and the vascular endothelial growth factor receptor-2 (VEGFR-2). OSI-930 is designed to target both cancer cell proliferation and blood vessel growth (angiogenesis) in selected tumors. In preclinical studies, OSI-930 shows broad efficacy in tumor models representative of small cell lung cancer, glioblastoma, colorectal, renal, head and neck, non-small cell lung cancer and gastric cancers." assertion.
- drugbank:DB05913 identifier "drugbank:DB05913" assertion.
- drugbank:DB05913 title "OSI-930" assertion.
- drugbank:DB05913 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05913 drugbank_vocabulary:drugbank-id "DB05913" assertion.
- drugbank:DB05913 bio2rdf_vocabulary:x-identifiers.org DB05913 assertion.
- drugbank:DB05913 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05913" assertion.
- drugbank:DB05913 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05913 bio2rdf_vocabulary:identifier "DB05913" assertion.